PAS
CLB icon

Point72 Asia (Singapore)’s Core Laboratories CLB Stock Holding History

Point72 Asia (Singapore)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$170K Buy
13,792
+6,540
+90% +$76.7K 0.03% 336
2025
Q2 		$83.5K Buy
+7,252
New +$86K 0.01% 508
2025
Q1 		– Sell
-311
Closed -$5.38K – 917
2024
Q4 		$5.38K Buy
+311
New +$6K ﹤0.01% 785

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Point72 Asia (Singapore)'s CLB Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its Core Laboratories (CLB) stake by 90% in Q3 2025, buying an estimated $76.7K and bringing the position to 13,792 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #336.

Point72 Asia (Singapore) first reported a position in CLB in Q4 2024 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Point72 Asia (Singapore) held 13,792 shares of Core Laboratories worth $170K as of Q3 2025.
  • Point72 Asia (Singapore) bought 6,540 Core Laboratories shares in Q3 2025, an estimated $76.7K.
  • Core Laboratories made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #336 holding.
  • Point72 Asia (Singapore) first reported a position in Core Laboratories in Q4 2024 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.